Investment Summary |
|
|---|---|
| Date | 2022-12-11 |
| Target | Acotec |
| Sector | Medical Products |
| Investor(s) | Boston Scientific |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1979 |
| Sector | Medical Products |
| Employees | 48,000 |
| Revenue | 16.7B USD (2024) |
Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 61 of 70 |
| Sector: Medical Products M&A | 46 of 53 |
| Type: Stake Purchase M&A Deals | 4 of 4 |
| Country: China M&A | 1 of 1 |
| Year: 2022 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-11-29 |
Apollo Endosurgery
Austin, Texas, United States Apollo Endosurgery is a developer of therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease. The company concluded mid-stage clinical development of drug candidates iSONEP™ (sphingomab) in wet age-related macular degeneration and ASONEP™ (anti-S1P antibody for systemic delivery) in renal cell carcinoma in 2015. Apollo Endosurgery was incorporated in 2005 and is based in Austin, Texas. |
Buy | $615M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-09-18 |
Relievant Medsystems
Edina, Minnesota, United States Relievant Medsystems is a private, clinical-stage medical device company that is developing a novel treatment for chronic low back pain. The company's Intercept product, currently under development, is a minimally invasive system that allows a spine surgeon to target low back pain by ablating a nerve target within the vertebral body. Relievant Medsystems was formed in 2004 and is based in Edina, Minnesota. |
Buy | $850M |
